Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-036913
Filing Date
2021-06-01
Accepted
2021-06-01 18:06:07
Documents
1
Period of Report
2021-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4023
  Complete submission text file 0001209191-21-036913.txt   5487
Mailing Address C/O PERCEPTIVE ADVISORS LLC 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address
EDELMAN JOSEPH (Reporting) CIK: 0001164426 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 21986825

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)